We are live on ! Find out more
OIC

Orion Investment Company Portfolio holdings

AUM $343M
1-Year Est. Return 52.59%
This Fund
S&P 500
This Quarter Est. Return
+11.87%
1 Year Est. Return
+52.59%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$251M
AUM Growth
-$6.57M
Cap. Flow
+$4.26M
Cap. Flow %
1.7%
Top 10 Hldgs %
59.38%
Holding
66
New
–
Increased
28
Reduced
10
Closed
1
Avg Time Held
2 quarters
Top 10 Avg Time Held
1.5 quarters
Top 20 Avg Time Held
1.8 quarters

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$1.43M
2
RGLD icon
Royal Gold
RGLD
+$1.22M
3
ASML icon
ASML
ASML
+$794K
4
CDNS icon
Cadence Design Systems
CDNS
+$697K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$420K

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$1.73M
2
BIIB icon
Biogen
BIIB
+$141K
3
BLUE
bluebird bio
BLUE
+$117K
4
HII icon
Huntington Ingalls Industries
HII
+$103K
5
IONS icon
Ionis Pharmaceuticals
IONS
+$94.4K

Sector Composition

Rank Sector Weight
1 Technology 39.85%
2 Healthcare 26.1%
3 Industrials 12.81%
4 Consumer Staples 7.19%
5 Energy 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$3.88T
$44.6M 17.81%
105,914
+297
+0.3% +$127K
2024 Q2
2 quarters
REGN icon
2
Regeneron Pharmaceuticals
REGN
$76.1B
$21.3M 8.49%
29,886
+500
+2% +$420K
2024 Q2
2 quarters
QCOM icon
3
Qualcomm
QCOM
$188B
$18.9M 7.52%
122,747
+1,117
+0.9% +$183K
2024 Q2
2 quarters
IONQ icon
4
IonQ
IONQ
$16B
$9.95M 3.97%
238,265
+2,990
+1% +$75K
2024 Q2
2 quarters
PG icon
5
Procter & Gamble
PG
$350B
$9.95M 3.97%
59,355
+968
+2% +$165K
2024 Q2
2 quarters
BPMC
6
DELISTED
Blueprint Medicines
BPMC
$9.48M 3.78%
108,670
+60
+0.1% +$5.5K
2024 Q2
2 quarters
XOM icon
7
ExxonMobil
XOM
$693B
$9.21M 3.67%
85,602
+1,913
+2% +$224K
2024 Q2
2 quarters
PLTR icon
8
Palantir
PLTR
$478B
$8.84M 3.53%
116,910
+570
+0.5% +$33.2K
2024 Q2
2 quarters
PH icon
9
Parker-Hannifin
PH
$119B
$8.78M 3.5%
13,810
+35
+0.3% +$23.2K
2024 Q2
2 quarters
IOVA icon
10
Iovance Biotherapeutics
IOVA
$6.03B
$7.85M 3.13%
1,060,755
+154,470
+17% +$1.43M
2024 Q2
2 quarters
CMI icon
11
Cummins
CMI
$71.6B
$7.64M 3.05%
21,912
+88
+0.4% +$30.9K
2024 Q2
2 quarters
ABT icon
12
Abbott
ABT
$170B
$7.63M 3.04%
67,428
-75
-0.1% -$8.67K
2024 Q2
2 quarters
IONS icon
13
Ionis Pharmaceuticals
IONS
$7.2B
$7.55M 3.01%
216,000
-2,525
-1% -$94.4K
2024 Q2
2 quarters
NEE icon
14
NextEra Energy
NEE
$161B
$7.1M 2.83%
99,028
+3,715
+4% +$289K
2024 Q2
2 quarters
HSY icon
15
Hershey
HSY
$32.7B
$5.76M 2.3%
34,017
-49
-0.1% -$8.79K
2024 Q2
2 quarters
GD icon
16
General Dynamics
GD
$89.3B
$5.32M 2.12%
20,198
+197
+1% +$56.7K
2024 Q2
2 quarters
BIIB icon
17
Biogen
BIIB
$32.3B
$4.85M 1.94%
31,721
-834
-3% -$141K
2024 Q2
2 quarters
SHOP icon
18
Shopify
SHOP
$212B
$4.03M 1.61%
37,914
+360
+1% +$35K
2024 Q2
2 quarters
AAPL icon
19
Apple
AAPL
$4.97T
$3.58M 1.43%
14,293
+500
+4% +$118K
2024 Q2
2 quarters
CNI icon
20
Canadian National Railway
CNI
$70.6B
$3.47M 1.38%
34,154
-550
-2% -$60.2K
2024 Q2
2 quarters
INTC icon
21
Intel
INTC
$566B
$3.1M 1.24%
154,511
-76,774
-33% -$1.73M
2024 Q2
2 quarters
CDNS icon
22
Cadence Design Systems
CDNS
$96.1B
$2.85M 1.14%
9,500
+2,396
+34% +$697K
2024 Q2
2 quarters
RGLD icon
23
Royal Gold
RGLD
$19.6B
$2.84M 1.13%
21,516
+8,431
+64% +$1.22M
2024 Q2
2 quarters
ASML icon
24
ASML
ASML
$680B
$2.5M 1%
3,612
+1,105
+44% +$794K
2024 Q2
2 quarters
HII icon
25
Huntington Ingalls Industries
HII
$10.4B
$2.4M 0.96%
12,676
-478
-4% -$103K
2024 Q2
2 quarters
1
2 3

Similar funds

SP
Saranac Partners London $343M AUM 11.5% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
WA
Wealthstar Advisors Plano, Texas $343M AUM 49.94% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $342M AUM 36.47% 1-Year Est. Return
ITB
Idaho Trust Bank Boise, Idaho $342M AUM 17.92% 1-Year Est. Return
CP
Capital Planning Bellevue, Washington $343M AUM 19.13% 1-Year Est. Return
BL
BCWM LLC Overland Park, Kansas $342M AUM 14.2% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $342M AUM 31.45% 1-Year Est. Return

Orion Investment Company's Q4 2024 Portfolio in Review

As of Q4 2024, Orion Investment Company held 66 positions worth $251M, down 2.6% from $257M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 1.5%. Orion Investment Company opened no new positions and exited 1, leaving the 66-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

  • Orion Investment Company added most to Iovance Biotherapeutics in Q4 2024, an estimated $1.43M increase.
  • Orion Investment Company's biggest Q4 2024 reduction was Intel, cutting an estimated $1.73M.
  • Orion Investment Company fully exited bluebird bio in Q4 2024, selling an estimated $117K.
  • Orion Investment Company's ten largest holdings make up 59% of its $251M portfolio in Q4 2024.
  • Orion Investment Company opened 0 new positions and closed 1 in Q4 2024.
  • Orion Investment Company's portfolio value fell 2.6% quarter-over-quarter to $251M.

Based on Orion Investment Company's 13F filing for Q4 2024, filed 13 Feb 2025.